Biogen - 29 Year Stock Price History | BIIB

Historical daily share price chart and data for Biogen since 1991 adjusted for splits. The latest closing stock price for Biogen as of February 28, 2020 is 308.39.
  • The all-time high Biogen stock closing price was 475.98 on March 20, 2015.
  • The Biogen 52-week high stock price is 374.99, which is 21.6% above the current share price.
  • The Biogen 52-week low stock price is 215.78, which is 30% below the current share price.
  • The average Biogen stock price for the last 52 weeks is 259.70.
Biogen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 305.4815 294.2400 341.0400 268.8500 308.3900 3.93%
2019 263.5519 304.6900 338.9600 216.7100 296.7300 -1.39%
2018 313.6443 334.1700 383.8300 257.5200 300.9200 -5.54%
2017 291.0549 291.7100 344.5800 246.5400 318.5700 12.34%
2016 280.1990 294.6200 330.1100 224.6000 283.5800 -7.43%
2015 352.5829 342.0100 475.9800 256.0400 306.3500 -9.75%
2014 317.9830 280.3300 360.6700 273.5175 339.4500 21.42%
2013 215.2810 150.0000 295.8800 142.8200 279.5720 91.00%
2012 136.5151 113.5000 156.0600 113.5000 146.3700 33.00%
2011 91.9759 67.2000 118.7200 65.0800 110.0500 64.13%
2010 56.3579 53.6400 68.2200 46.2200 67.0500 25.33%
2009 48.9437 48.4900 53.7000 42.1300 53.5000 12.32%
2008 55.4272 55.8700 71.3800 39.0200 47.6300 -16.32%
2007 56.5874 49.3300 82.5100 43.1300 56.9200 15.71%
2006 45.9898 46.7400 52.2600 40.7300 49.1900 8.64%
2005 43.2715 66.2900 67.8000 33.3500 45.2800 -32.02%
2004 57.2480 36.9400 67.9200 36.9400 66.6100 81.50%
2003 34.4312 34.3400 41.5700 28.0900 36.7000 10.64%
2002 47.4686 68.1500 70.9600 30.1500 33.1700 -51.88%
2001 56.9957 59.2500 74.5700 35.6900 68.9300 9.09%
2000 44.2699 31.0833 75.0833 19.1267 63.1867 92.94%
1999 14.0875 7.7917 32.7500 6.8550 32.7500 318.09%
1998 5.4740 5.6450 8.0200 2.9167 7.8333 36.71%
1997 4.6884 3.7500 7.6667 2.7083 5.7300 44.76%
1996 3.7283 3.1867 5.0200 2.4367 3.9583 21.79%
1995 1.1416 0.3950 3.8550 0.3750 3.2500 815.49%
1994 0.5854 0.9367 1.0833 0.3550 0.3550 -62.96%
1993 0.9571 1.5000 1.5000 0.6250 0.9583 -34.29%
1992 1.6281 2.1250 3.3333 1.0417 1.4583 -32.69%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $53.974B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $120.026B 13.72
CSL (CSLLY) Australia $93.989B 0.00
Gilead Sciences (GILD) United States $91.816B 11.83
Vertex Pharmaceuticals (VRTX) United States $57.895B 52.54
Regeneron Pharmaceuticals (REGN) United States $47.485B 20.11
Illumina (ILMN) United States $38.210B 39.50
Alexion Pharmaceuticals (ALXN) United States $20.389B 9.48
Seattle Genetics (SGEN) United States $18.657B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.001B 0.00
Incyte (INCY) United States $16.440B 35.27
BioMarin Pharmaceutical (BMRN) United States $16.134B 690.92
Genmab (GNMSF) Denmark $14.343B 46.13
Galapagos (GLPG) Belgium $13.996B 30.57
Alnylam Pharmaceuticals (ALNY) United States $12.665B 0.00
Exact Sciences (EXAS) United States $11.959B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.059B 51.67
BeiGene (BGNE) Cayman Islands $9.466B 0.00
Moderna (MRNA) United States $8.804B 0.00
Sarepta Therapeutics (SRPT) United States $8.374B 0.00
QIAGEN (QGEN) Netherlands $8.224B 25.33
BioNTech SE (BNTX) Germany $7.666B 0.00
Bio-Techne Corp (TECH) United States $7.402B 50.66
Guardant Health (GH) United States $7.246B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.469B 17.12
Ascendis Pharma (ASND) Denmark $6.207B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.022B 0.00
Reata Pharmaceuticals (RETA) United States $5.712B 0.00
Exelixis (EXEL) United States $5.625B 18.06
ARGENX SE-ADR (ARGX) Netherlands $5.470B 0.00
Amarin (AMRN) Ireland $5.240B 0.00
Acceleron Pharma (XLRN) United States $4.595B 0.00
China Biologic Products (CBPO) China $4.538B 25.56
Repligen (RGEN) United States $4.484B 82.00
Global Blood Therapeutics (GBT) United States $3.720B 0.00
Bluebird Bio (BLUE) United States $3.714B 0.00
Mirati Therapeutics (MRTX) United States $3.670B 0.00
Adaptive Biotechnologies (ADPT) United States $3.577B 0.00
MorphoSys AG (MOR) Germany $3.452B 0.00
Zai Lab (ZLAB) China $3.253B 0.00
Alkermes (ALKS) Ireland $3.097B 245.38
Ultragenyx Pharmaceutical (RARE) United States $3.076B 0.00
Immunomedics (IMMU) United States $3.029B 0.00
Genmab (GMAB) Denmark $3.010B 11.81
CRISPR Therapeutics AG (CRSP) Switzerland $3.008B 50.97
Blueprint Medicines (BPMC) United States $2.938B 0.00
Emergent Biosolutions (EBS) United States $2.877B 19.97
NeoGenomics (NEO) United States $2.872B 125.04
MyoKardia (MYOK) United States $2.842B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.810B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.805B 0.00
Halozyme Therapeutics (HALO) United States $2.802B 0.00
Amicus Therapeutics (FOLD) United States $2.379B 0.00
UniQure (QURE) Netherlands $2.260B 0.00
Arena Pharmaceuticals (ARNA) United States $2.210B 5.77
RA PHARMCTL INC (RARX) United States $2.193B 0.00
Fate Therapeutics (FATE) United States $2.176B 0.00
Insmed (INSM) United States $2.173B 0.00
Principia Biopharma (PRNB) United States $2.068B 0.00
Eidos Therapeutics (EIDX) United States $1.887B 0.00
Epizyme (EPZM) United States $1.864B 0.00
Denali Therapeutics (DNLI) United States $1.827B 0.00
Ligand Pharmaceuticals (LGND) United States $1.815B 53.01
Alector (ALEC) United States $1.785B 0.00
Arvinas (ARVN) United States $1.599B 0.00
Zymeworks (ZYME) Canada $1.564B 0.00
Akcea Therapeutics (AKCA) United States $1.538B 35.61
REGENXBIO (RGNX) United States $1.505B 0.00
Coherus BioSciences (CHRS) United States $1.346B 16.13
Dicerna Pharmaceuticals (DRNA) United States $1.328B 0.00
Revance Therapeutics (RVNC) United States $1.317B 0.00
Myriad Genetics (MYGN) United States $1.288B 22.74
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Zealand Pharma (ZEAL) Denmark $1.255B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.220B 0.00
Editas Medicine (EDIT) United States $1.151B 0.00
Intra-Cellular Therapies (ITCI) United States $1.135B 0.00
Twist Bioscience (TWST) United States $1.073B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.026B 0.00
Athenex (ATNX) United States $0.972B 0.00
PHARMA MAR SA (PHMMF) Spain $0.932B 0.00
DBV Technologies S.A (DBVT) France $0.912B 0.00
Mesoblast (MESO) Australia $0.859B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Cytokineticsorporated (CYTK) United States $0.824B 0.00
Adverum Biotechnologies (ADVM) United States $0.805B 0.00
Codexis (CDXS) United States $0.777B 0.00
Sangamo Therapeutics (SGMO) United States $0.773B 0.00
Heska (HSKA) United States $0.764B 0.00
Vericel (VCEL) United States $0.675B 100.07
Cellectis S.A (CLLS) France $0.672B 0.00
Arcus Biosciences (RCUS) United States $0.661B 0.00
Retrophin (RTRX) United States $0.647B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.614B 0.00
Intrexon (PGEN) United States $0.605B 0.00
GENFIT S.A (GNFT) France $0.595B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.590B 5.19
Anika Therapeutics (ANIK) United States $0.587B 20.06
ANI Pharmaceuticals (ANIP) United States $0.583B 10.53
Kadmon Holdings (KDMN) United States $0.578B 0.00
Intellia Therapeutics (NTLA) United States $0.568B 0.00
UROGEN PHARMA (URGN) United States $0.559B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.541B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.519B 0.00
Bellus Health (BLU) Canada $0.509B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.479B 11.08
Compugen (CGEN) Israel $0.465B 0.00
NantKwest (NK) United States $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Inovio Pharmaceuticals (INO) United States $0.442B 0.00
BioDelivery Sciences (BDSI) United States $0.433B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
Mersana Therapeutics (MRSN) United States $0.419B 0.00
Cue Biopharma (CUE) United States $0.410B 0.00
Cel-Sci (CVM) United States $0.399B 0.00
AnaptysBio (ANAB) United States $0.396B 0.00
Merus (MRUS) Netherlands $0.392B 0.00
Puma Biotechnology (PBYI) United States $0.391B 0.00
Precision BioSciences (DTIL) United States $0.389B 0.00
PDL BioPharma (PDLI) United States $0.386B 9.66
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
Pfenex (PFNX) United States $0.380B 0.00
Novavax (NVAX) United States $0.379B 0.00
Kindred Biosciences (KIN) United States $0.378B 0.00
Clovis Oncology (CLVS) United States $0.375B 0.00
Agenus (AGEN) United States $0.367B 0.00
Sorrento Therapeutics (SRNE) United States $0.366B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.358B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.345B 0.00
Dynavax Technologies (DVAX) United States $0.340B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Cellular Biomedicine (CBMG) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.303B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.294B 2.04
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
Stemline Therapeutics (STML) United States $0.290B 0.00
Albireo Pharma (ALBO) United States $0.288B 0.00
Syros Pharmaceuticals (SYRS) United States $0.282B 0.00
MannKind (MNKD) United States $0.278B 0.00
OSMOTICA PHARM (OSMT) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.269B 0.00
Kamada (KMDA) Israel $0.264B 10.96
Starpharma Holdings (SPHRY) Australia $0.257B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.256B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.247B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Aduro Biotech (ADRO) United States $0.239B 0.00
VBI Vaccines (VBIV) United States $0.234B 0.00
IVERIC Bio (ISEE) United States $0.224B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Kala Pharmaceuticals (KALA) United States $0.216B 0.00
Sutro Biopharma (STRO) United States $0.213B 0.00
Protagonist Therapeutics (PTGX) United States $0.213B 0.00
XOMA (XOMA) United States $0.208B 0.00
Geron (GERN) United States $0.208B 0.00
Alcobra (ARCT) United States $0.204B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
VTv Therapeutics (VTVT) United States $0.203B 0.00
Prometic Life Sciences (LMNL) Canada $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.194B 0.00
Arbutus Biopharma (ABUS) Canada $0.193B 0.00
Athersys (ATHX) United States $0.188B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
Affimed (AFMD) Germany $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Exicure (XCUR) United States $0.171B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.160B 8.23
Dyadic (DYAI) United States $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
Selecta Biosciences (SELB) United States $0.153B 0.00
Fortress Biotech (FBIO) United States $0.151B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
Verastem (VSTM) United States $0.142B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.139B 0.00
Aptinyx (APTX) United States $0.137B 0.00
VolitionRX (VNRX) Singapore $0.137B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
CorMedix Inc (CRMD) United States $0.133B 0.00
Arsanis (XFOR) United States $0.132B 0.00
Happiness Biotech Group (HAPP) China $0.129B 0.00
ARAVIVE, INC (ARAV) United States $0.128B 0.00
PHASEBIO PHARMA (PHAS) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.107B 0.00
Palatin Technologies (PTN) United States $0.106B 2.89
OvaScience (MLND) United States $0.104B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Prima BioMed (IMMP) Australia $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Adocia (ADOCY) France $0.086B 0.00
Applied Genetic Technologies (AGTC) United States $0.085B 0.00
Proteostasis Therapeutics (PTI) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Pluristem Therapeutics (PSTI) Israel $0.068B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 4.29
Menlo Therapeutics (MNLO) United States $0.066B 0.00
IBio (IBIO) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.065B 0.00
Acorda Therapeutics (ACOR) United States $0.064B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Trevena (TRVN) United States $0.061B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Advaxis (ADXS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
Curis (CRIS) United States $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Organovo Holdings (ONVO) United States $0.041B 0.00
TOCAGEN INC (TOCA) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.024B 0.00
Oncobiologics (OTLK) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.014B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.003B 0.00